"生泰" 鹽酸去甲羥麻黃鹼(PHENYLEPHRINE HCl "SYN-TECH") |
衛署藥製字第048154號 |
PHENYLEPHRINE HCL |
2016-07-21 |
鼻能爽液(B.N. SOLUTION) |
內衛藥製字第004837號 |
DIPHENHYDRAMINE, PHENYLEPHRINE, CHLOROBUTANOL (TRICHLORISOBUTYLIC ALCOHOL) |
2015-12-21 |
"尼斯可"噴鼻液(NASAL SPRAY "NYSCO") |
衛署藥製字第021719號 |
CHLORPHENIRAMINE MALEATE, NAPHAZOLINE NITRATE |
2016-03-28 |
鹽酸麻黃素(EPHEDRINE HCL) |
衛署藥輸字第021245號 |
EPHEDRINE HCL (EQ TO EPHEDRINE HYDROCHLORIDE) |
2016-07-12 |
"人生" 噴速點鼻液外用(NAZAL SPRAY "JEN SHENG") |
內衛藥製字第012086號 |
CHLORPHENIRAMINE MALEATE, NAPHAZOLINE HCL |
2015-11-04 |
鹽酸麻黃素(Ephedrine Hydrochloride) |
衛署藥陸輸字第000396號 |
|
2016-04-11 |
"正峰"左旋鹽酸去甲羥麻黃鹼((-)Phenylephrine Hydrochloride "C.F.") |
衛署藥製字第057867號 |
|
2017-09-30 |
“中美”鼻舒康噴鼻液(Bisoucan Nasal Spray“C.M.”) |
衛署藥製字第049759號 |
DIPHENHYDRAMINE HCL, NAPHAZOLINE HCL, PROCAINE HCL |
2014-01-21 |
奧每達佐林鼻用噴液劑(OXYMETAZOLINE Nasal Spray) |
衛署藥製字第014620號 |
OXYMETAZOLINE HCL |
2015-01-30 |
“汎生”歐瑞芬噴鼻液 0.1%(Orzefin Nasal solution 0.1%“Panbiotic”) |
衛署藥製字第055891號 |
XYLOMETAZOLINE HCL |
2015-11-18 |
“汎生”歐瑞芬噴鼻液 0.1%(Orzefin Nasal solution 0.1%“Panbiotic”) |
衛署藥製字第055891號 |
XYLOMETAZOLINE HCL |
2015-11-18 |
"羅得"利鼻通液0.05%(LIBITON NASAL SOLUTION 0.05% "R.T.") |
衛署藥製字第033076號 |
OXYMETAZOLINE HCL |
2016-07-11 |
康康鼻通液 0.1%(CON -CON NASAL SOLUTION 0.1%) |
衛署藥製字第044506號 |
XYLOMETAZOLINE HCL |
2016-04-07 |
〝華盛頓〞樂寧噴鼻液(NASLINE NASAL SOLUTION "W.P.") |
衛署藥製字第044368號 |
OXYMETAZOLINE HCL |
2016-05-18 |
〝華盛頓〞樂寧噴鼻液(NASLINE NASAL SOLUTION "W.P.") |
衛署藥製字第044368號 |
OXYMETAZOLINE HCL |
2016-05-18 |
塞羅通噴鼻液(Xylo-POS Nasal Spray Solution) |
衛署藥輸字第024930號 |
XYLOMETAZOLINE HCL |
2014-05-05 |
塞羅通噴鼻液(Xylo-POS Nasal Spray Solution) |
衛署藥輸字第024930號 |
XYLOMETAZOLINE HCL |
2014-05-05 |
"大豐"鼻速通噴鼻液(BISTON NASAL SOLUTION "T.F.") |
衛署藥製字第033483號 |
CHLORPHENIRAMINE MALEATE, NAPHAZOLINE HCL, BENZETHONIUM CHLORIDE |
2016-02-16 |
"中美"鼻那通噴鼻液0.1%(奧每達佐林)(BERTON NASAL SPRAY 0.1% (OXYMETAZOLINE) "C.M.") |
衛署藥製字第038772號 |
OXYMETAZOLINE HCL |
2016-04-08 |
"中美"鼻那通噴鼻液0.1%(奧每達佐林)(BERTON NASAL SPRAY 0.1% (OXYMETAZOLINE) "C.M.") |
衛署藥製字第038772號 |
OXYMETAZOLINE HCL |
2016-04-08 |